Reply to: The informed majority could help make research into Alzheimer's disease fairer and more efficient
J Am Geriatr Soc
.
2022 Jun;70(6):1883-1885.
doi: 10.1111/jgs.17757.
Epub 2022 Mar 28.
Authors
Michael J DiStefano
1
2
,
G Caleb Alexander
3
4
5
,
Gerard F Anderson
1
5
Affiliations
1
Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
2
Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.
3
Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
4
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
5
Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA.
PMID:
35343584
DOI:
10.1111/jgs.17757
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Alzheimer Disease*
Humans
Informed Consent
Mental Competency
Grants and funding
Arnold Ventures